Welcome to TradeKey, Join Free | Sign In

or
❯
Contact Us
❯
BOOK A CALL
Book Call On Your Favorite Time
Code
🗘

By Signing Up. I agree to TradeKey.com Terms of Use, Privacy Policy, IPR and receive emails related to our services

Get Verified Buyers & Suppliers

Avail Free Consultation

Code
       


By Signing up. I agree to TradeKey.com Terms of Use, Privacy Policy, IPR and receive emails related to our services

no thanks


rh-G-CSF

  • China China  
  • Last Updated:
    Posted on: 13 Dec 2024

Buyer Information

RFQ Details

Shandong Kexing Bioproducts Co., Ltd. is a biotech pharmaceutical ***** the development, production and sales of genetic engineering product and microecological product. The company is mainly engaged in the production and sale of three products including recombinant human erythropoietin injection (rh-EPO), recombinant human granulocyte colony-stimulating factor injection(rh-G-CSF) and Changlekang whic is Oral Clostridium Butyricum and Bifdobacterium Capsules/powder. rh-EPO is the first genetic engineering and product put into domestic market, making our country the fourth to develop the product successfully following America, Japan and Germany in the world. In 1997, the product won the first EPO and new drug certificate and the first GNP certificate issued by our SFDA.
The company has successfully developed the market in India, Egypt, Indonesia, the Philippines, Pakistan and Brazil. New market in Iran, Chile and Syria are being developed.

Hope that we could cooperate in distribution of our finished drugs.


People who quote for this RFQ also looked at

Refine by popular tags

recombinant human granulocyte

Recommended RFQs

Connect with us:

Copyright © 2024 TradeKey.com

Created in 6.28133 seconds